CD79A and pneumococcal infection: In conclusion, our present study demonstrates that mucosal vaccination with live S. mitis serotype 5 protects against infection by S. pneumoniae serotype 5, and induces strong IgG/IgA and Th17 responses against pneumococcal infection at the local and systemic/peripheral tissues.